Skip to content

Study on the need for lifestyle interventions in people with chronic pain

Assessing Lifestyle medicine Integration in Chronic pain care: a patient interest Evaluation (ALICE) - ALICE

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON58547
Enrollment
500
Registered
2026-04-03
Start date
2026-05-01
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic pain Chronic pain

Interventions

There is no investigational product and no therapeutic intervention. The study consists of a one-time online questionnaire and the use of a predefined limited set of routine clinical data for particip

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Adult patients aged 18 years or olderInitial outpatient consultation at the Erasmus MC Center for Pain Medicine during the inclusion periodPain duration longer than 3 monthsAdequate comprehension of the Dutch language

Exclusion criteria

Exclusion criteria: Pain duration of 3 months or shorterPain attributable to ongoing malignant disease

Design outcomes

Primary

MeasureTime frame
The primary endpoint is the proportion of participants with a non-missing response to the primary questionnaire item who indicate whether or not they would like lifestyle medicine topics to be discussed during their consultation with the pain specialist.

Secondary

MeasureTime frame
Secondary outcomes include interest in support and discussion across Lifestyle Wheel domains, prior lifestyle-related interventions, familiarity with lifestyle interventions, perceived usefulness of lifestyle interventions for pain complaints, preferred timing of a lifestyle conversation, and exploratory differences across predefined patient categories such as age group, sex, pain duration, referral source, diagnostic category, BMI if available, routinely documented substance use variables, and routinely available PROM outcomes. In addition, response, participation, and completion rates will be described.

Countries

Netherlands

Contacts

Public ContactJ. Brink

Erasmus MC, Universitair Medisch Centrum Rotterdam

alice@erasmusmc.nl010-7040140

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: May 1, 2026